Altering the intracellular pH to an acidic condition by combination of MCT1/2 inhibition and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) knockdown was shown to decrease breast cancer cell survival, indicating that interfering with the intracellular pH in cancer cells could be an effective therapeutic strategy [87]. The gene discussed is GAPDH; the disease is breast cancer.